🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effects of Agility Training With and Without Foot Mobilization In Patellofemoral Pain Syndrome.

RecruitingNAAges 20 Years - 40 YearsAllRiphah International University
NCT06674707 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Patellofemoral pain syndrome (PFPS) is referred to as peripatellar or retro-patellar pain, which is characterized by alterations in the physical and biomechanical features of the patellofemoral joint. Risk factors for PFPS include: anatomic anomalies, mal-alignment and altered biomechanics of the lower extremity, muscle dysfunction, patellar hypermobility, poor quadriceps, or iliotibial band flexibility, surgery, tight lateral structures, training errors or overuse and trauma. The aim of this study is to compare the effects of foot mobilization with and without agility training on pain, balance and functional performance in patellofemoral pain syndrome.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Clinical signs of patellofemoral pain syndrome such as retro patellar pain, crepitation, and pain with patellar grinding more than 6 months. * Both genders of 20-40 years of age. * Presence of pain on step down from a 25 step or double leg squat and sitting with knee bent greater than 15 min. * Pain more than 4 on NPRS scale. * Individual with anterior left/right asymmetries greater than 4 cm on Y balance test * Excessive calcaneal eversion measured at 6° in the relaxed posture(6). Exclusion Criteria: * History of ligament and meniscal injury. * History of lower limb fractures. * History of post-surgical condition of lower limb * History of systemic, connective tissue or neurologic condition
💊

What it tests

  • Agility Training with Foot mobilization.
  • Agility Training without Foot mobilization
📍

Where

1 site
Al- Rehman Hospital
Lahore, Pakistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy